BN Business News
Add your company to Business Communicator →

Regulation & law · 10/09/2021Updated: 10/17/2026 · 1 min read

National Institute of Allergy and Infectious Diseases to Grant Exclusive Patent License for West Nile Virus Vaccine

Summary

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Blue Water Vaccines, Inc. to commercialize a live-attenuated vaccine for West Nile Virus.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights

Business insights →